SOURCE: Alpharma Inc.

October 18, 2007 12:22 ET

Alpharma Announces Third Quarter 2007 Conference Call

BRIDGEWATER, NJ--(Marketwire - October 18, 2007) - Alpharma Inc. (NYSE: ALO) announced that the company will release its third quarter 2007 earnings after the market close on Monday, October 29, 2007. Alpharma management will conduct a conference call / webcast on Tuesday, October 30, 2007 beginning at 8:30 AM Eastern Daylight Time to discuss its third quarter results.

The call will be open to all interested parties and may be accessed by using the following information:

                CONFERENCE CALL ACCESS
          Domestic Dial In:       (800) 351-4892
          International Dial In:  (334) 323-7224
          Conference Call ID:     ALPHARMA

Investors can access the call in a "listen only" mode via the Internet at http://www.streetevents.com.

In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Tuesday, October 30, 2007 at 12:00 PM Eastern Daylight Time until Tuesday, November 13, 2007 Eastern Standard Time at midnight. The rebroadcast may be accessed on the Internet at http://www.streetevents.com or by telephone using the following information:

                  REBROADCAST ACCESS
          Domestic Dial In:       (877) 919-4059
          International Dial In:  (334) 323-7226
          Participant Code:       43027254

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and an innovative pharmaceutical product pipeline that consists of several novel approaches to treat pain, including the Flector® Patch (diclofenac epolamine topical patch), which is expected to launch in early 2008. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Contact Information

  • Contact:
    Kathleen Makrakis
    VP, Investor Relations
    Email Contact
    908-566-3918